Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for NORGESTIMATE AND ETHINYL ESTRADIOL from Glenmark Pharmaceuticals, enabling the generic oral contraceptive to be mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORGESTIMATE AND ETHINYL ESTRADIOL (norgestimate and ethinyl estradiol)

Snippet

SUPPL AP for NORGESTIMATE AND ETHINYL ESTRADIOL (NORGESTIMATE AND ETHINYL ESTRADIOL)